- Q1 2024 Fresenius SE & Co KGaA Earnings Call TranscriptMay 08, 2024€28.48 (+1.24%)Earnings
- Full Year 2023 Fresenius SE & Co KGaA Earnings Call TranscriptFeb 21, 2024€26.2 (+0.61%)Earnings
- Q3 2023 Fresenius SE & Co KGaA Earnings Call TranscriptNov 02, 2023€25.72 (+5.84%)Earnings
- Q2 2023 Fresenius SE & Co KGaA Earnings Call TranscriptAug 02, 2023€28.57 (-0.38%)Earnings
- Fresenius SE & Co KGaA Capital Markets Day 2023 TranscriptMay 25, 2023
- Fresenius SE & Co KGaA Annual Shareholders Meeting TranscriptMay 17, 2023
- Q1 2023 Fresenius SE & Co KGaA Earnings Call TranscriptMay 09, 2023€27.66 (+8.73%)Earnings
- Q4 2022 Fresenius SE & Co KGaA Earnings Call TranscriptFeb 22, 2023€27.59 (-4.37%)Earnings
- Q3 2022 Fresenius SE & Co KGaA Earnings Call TranscriptNov 01, 2022€23.26 (+4.96%)Earnings
- Preliminary Q2 2022 Fresenius SE & Co KGaA Earnings Call TranscriptJul 28, 2022€25.02 (-8.15%)Earnings
- Fresenius SE & Co KGaA Annual Shareholders Meeting TranscriptMay 13, 2022
- Q1 2022 Fresenius SE & Co KGaA Earnings Call TranscriptMay 04, 2022€35.07 (+3.14%)Earnings
- Fresenius SE & Co KGaA and Fresenius Kabi AG Conference Call on the Acquisition of Ivenix Inc and Majority Stake in mAbxience SA Call TranscriptMar 31, 2022
- Full Year 2021 Fresenius SE & Co KGaA Earnings Call TranscriptFeb 22, 2022€33.45 (-8.39%)Earnings
- Fresenius SE & Co KGaA at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Q3 2021 Fresenius SE & Co KGaA Earnings Call TranscriptNov 02, 2021€40.72 (+2.20%)Earnings
- Q2 2021 Fresenius SE & Co KGaA Earnings Call TranscriptJul 30, 2021€44.24 (-3.93%)Earnings
- Fresenius SE & Co KGaA at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Fresenius SE & Co KGaA Annual Shareholders Meeting TranscriptMay 21, 2021
- Q1 2021 Fresenius SE & Co KGaA Earnings Call TranscriptMay 06, 2021€41.51 (+0.47%)Earnings
- Full Year 2020 Fresenius SE & Co KGaA Earnings Call TranscriptFeb 23, 2021€35.56 (-0.70%)Earnings
- Fresenius SE & Co KGaA at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Q3 2020 Fresenius SE & Co KGaA Earnings Call TranscriptOct 29, 2020€31.49 (-2.53%)Earnings
- Fresenius SE & Co KGaA Annual Shareholders Meeting TranscriptAug 28, 2020
- Q2 2020 Fresenius SE & Co KGaA Earnings Call TranscriptJul 30, 2020€42.52 (-5.59%)Earnings
- Fresenius SE & Co KGaA at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- Q1 2020 Fresenius SE & Co KGaA Earnings Call TranscriptMay 06, 2020€39.7 (+1.02%)Earnings
- Full Year 2019 Fresenius SE & Co KGaA Earnings Call TranscriptFeb 20, 2020€49.65 (+2.26%)Earnings
- Fresenius SE & Co KGaA at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Fresenius SE & Co KGaA at Deutsche Bank Depositary Receipts Virtual Investor Conference TranscriptNov 13, 2019
- Q3 2019 Fresenius SE & Co KGaA Earnings Call TranscriptOct 29, 2019€45.69 (+4.57%)Earnings
- Q2 2019 Fresenius SE & Co KGaA Earnings Call TranscriptJul 30, 2019€44.85 (-2.13%)Earnings
- Fresenius SE & Co KGaA Annual Shareholders Meeting TranscriptMay 17, 2019
- Q1 2019 Fresenius SE & Co KGaA Earnings Call TranscriptMay 02, 2019€50.66 (+0.34%)Earnings
- Full Year 2018 Fresenius SE & Co KGaA Earnings Call TranscriptFeb 20, 2019€48.91 (+4.97%)Earnings
Fresenius SE & Co KGaA at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Good afternoon, good morning, ladies and gentlemen, and thank you for joining us for another session of our 41st Goldman Sachs Global Healthcare Conference webcast. My name is Veronika Dubajova, and I'm the medtech analyst at Goldman Sachs in London. And it is with great pleasure that I am joined today by the management team of Fresenius SE, Stephan Sturm, CEO; and Markus Georgi, Head of IR. Thank you guys for being here and greetings to Bad Homburg.
We are going to conduct the session entirely as Q&A. (Operator Instructions)
So Stephan and Markus, thank you for being here.
Questions & Answers
I want to start with the topic du jour, which is Helios and COVID. And this has obviously been a big discussion point for everyone. But can you maybe give us an update on where you are in terms of volume and utilization levels, both in Spain and in Germany? And how has the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)